NCT05526443View on ClinicalTrials.gov

Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 13, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

September 30, 2027

Conditions
Pancreatic CancerAdvanced Pancreatic Carcinoma
Interventions
DRUG

all approved chemotherapeutic agents from second line

all approved chemotherapeutic agents from second line

Trial Locations (12)

1060

RECRUITING

Barmherzige Schwestern Krankenhaus Wien, Vienna

1090

RECRUITING

Pancreatic Cancer Unit des Comprehensive Cancer Center (CCC-PCU), Vienna

1130

RECRUITING

St. Josef Krankenhaus Wien, Vienna

3100

RECRUITING

Universitätsklinikum St. Pölten, Sankt Pölten

3300

RECRUITING

Landesklinikum Amstetten, Amstetten

4010

RECRUITING

Ordensklinikum Linz, Linz

6020

RECRUITING

Universitätsklinikum Innsbruck,, Innsbruck

6511

RECRUITING

Krankenhaus St. Vinzenz Zams, Zams

6800

RECRUITING

Landesklinikum Feldkirch, Feldkirch

8020

RECRUITING

Krankenhaus der Barmherzigen Brüder, Graz

8036

RECRUITING

Medical University Graz Department of Oncology, Graz

9020

RECRUITING

Landesklinikum Klagenfurt, Klagenfurt

All Listed Sponsors
lead

Medical University of Graz

OTHER